A specialist in Endocrinology and Nutrition, with experience in managing diabetes, offers their opinion on the advisability of prescribing medications like Ozempic and Wegovy, which contain semaglutide and have recently gained popularity for their ability to induce weight loss. Currently, Wegovy is indicated for treating obesity, while Ozempic is used in patients with type 2 diabetes and obesity. To prescribe Ozempic, having type 2 diabetes is essential, making them effective options for treating this condition.
The specialist points out that both conditions are often related, and when evaluating the use of these medications, not only weight loss is analyzed, but also tolerance, side effects, and appropriate dosages. Some patients specifically request these treatments, but doctors must follow the guidelines from the Ministry of Health regarding their prescription and use. Although diabetes and obesity are chronic conditions, the use of semaglutide does not necessarily imply lifelong treatment.
Semaglutide works by eliminating insulin resistance in adiposity, which is beneficial for both diabetics and people with obesity. Its administration involves weekly subcutaneous injections, starting with minimal doses and adjusting based on the patient's progress. The importance of physical exercise alongside treatment is emphasized, as weight loss can facilitate engagement in physical activities.
This medication has shown significant benefits for cardiovascular health by reducing weight, which in turn motivates patients to adopt healthier habits. Additionally, semaglutide has proven effective in normalizing blood glucose levels and preventing serious complications in treated patients. Treatment with Wegovy is recommended for individuals with a specific Body Mass Index or with related comorbidities.
In summary, semaglutide has established itself as an effective therapeutic option in managing type 2 diabetes and obesity. Although it has gained popularity for its ability to induce weight loss, its action goes further by positively influencing cardiovascular health and preventing complications associated with these metabolic diseases. Its prescription should be supervised by specialists and accompanied by comprehensive follow-up in the medical consultation to ensure its effectiveness and safety.
